Shareholder meeting- my take

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

karlwest

Rank: Vice President [?]

Points: 1525 [?]

Votes: 42 Score: 3.1 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Shareholder meeting- my take

posted on Jan 19, 2011 03:03PM

From my perspective I thought the meeting was ok. Not great, not horrible. Cliff and Gloria seemed genuine and gracious but Johnson is another story. Johnson kept his dialog to smug one-word answers thinly veiling his comtempt for shareholders. According to Cliff, the MMP is strong and they are working on a resolution with TPL. The burnrate on aggregate is about $3.6 million per year for the entire portfolio, so it looks like wee'll be able to stay in business for a couple more years based on the current balance sheet.

It seems like we are selling MMP licenses which is great news and PDSG still has a pulse. Now we need to get in lockstep with TPL to get this engine firing on all cylinders.